Navigation Links
Open-access publication in JoVE receives sponsorship from Carl Zeiss MicroImaging
Date:10/11/2011

The Journal of Visualized Experiments (JoVE) will partner with Carl Zeiss Microscopy to support the sharing of scientific information through open access.

JoVE is the first and only peer-reviewed video journal indexed in PubMed and MEDLINE. Zeiss, a world-leading manufacturer of microscope technology based in Germany, will sponsor the publication of three open access video articles. For the three articles selected for publication, the JoVE team will film and edit the video article. Though the cost of the video is being sponsored, the final articles will undergo the same rigorous peer-review process as other JoVE content.

"Because these videos will be open to the public, this partnership with Zeiss will enable access to content that otherwise wouldn't be available," said Dr. Phill Jones, Editorial Director at JoVE.

Video publication is especially effective for demonstration of microscopy research techniques.

"As learning new techniques from written protocols can be challenging, Carl Zeiss Microscopy launched a campaign to support publication of a select number of microscropy protocols in JoVE," said Strategic Marketing Manager at Zeiss, Dr. Maya Everett.

"Our goal is both to support our customers who wish to publish in this video format as well as provide important training tools to scientists who are new to these techniques."


'/>"/>

Contact: Katherine Scott
katherine.scott@jove.com
617-996-5363
The Journal of Visualized Experiments
Source:Eurekalert

Page: 1

Related biology news :

1. Open-access membership: Reporting tool brings convenience and control
2. American Society for Microbiology to launch new open-access journal
3. BioMed Central celebrates excellence in open-access publishing
4. Earths life support systems discussed in an open-access special issue
5. Pensoft Publishers launch a new mycological open-access journal
6. Announcing Cell Reports -- a new open-access journal from Cell Press
7. Publication sets guidelines across cancer therapies: Ensuring the best in patient management
8. Autism Speaks responds to recent publications citing autism clusters in California
9. Multicultural education focus of new UOG publication
10. Lymphoma Research Foundation announces publication of Mantle Cell report
11. Linnaeus 2.0: First E-publication of new plant species
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016   Ginkgo Bioworks ... to industrial engineering, was today awarded as one ... selection of the world,s most innovative companies. Ginkgo ... scale for the real world in the nutrition, ... engineers work directly with customers including Fortune 500 ...
(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
Breaking Biology Technology: